AN2 Therapeutics Inc. Gains 64.66%
Fri, Aug 12, 2022 at 07:07 PM
AN2 Therapeutics Inc. (ANTX:NASDAQ) shot up at $19.38, representing a gain of 64.7%. On Fri, Aug 12, 2022, ANTX:NASDAQ hit a New 2-Week High of $19.38. The stock appeared on our News Catalysts scanner on Thu, Aug 11, 2022 at 06:28 PM in the 'INVESTOR UPDATE' category. From Fri, Jul 29, 2022, the stock recorded 80.00% Up Days and 72.73% Green Days
About AN2 Therapeutics Inc. (ANTX:NASDAQ)
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs.
Top 10 Gainers:
- Embark Technology Inc. (EMBK:NASDAQ), 84.8%
- Twin Vee PowerCats Co. (VEEE:NASDAQ), 77.5%
- AN2 Therapeutics Inc. (ANTX:NASDAQ), 64.66%
- Unity Biotechnology, Inc. (UBX:NASDAQ), 54.1%
- Conifer Holdings, Inc. (CNFR:NASDAQ), 46.18%
- GoHealth Inc. (GOCO:NASDAQ), 41.78%
- Everspin Technologies, Inc. (MRAM:NASDAQ), 39.69%
- Rani Therapeutics Holdings Inc. (RANI:NASDAQ), 37.55%
- ADDvantage Technologies Group, Inc. (AEY:NASDAQ), 35.46%
- Berkshire Grey Inc. (BGRY:NASDAQ), 31.65%